BioLineRx Ltd.
BLRX
$2.55
-$0.04-1.54%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/6/2025
-
MarketBeat
9/1/2026
-
TipRanks
8/31/2026
-
Seeking Alpha: Transcripts
8/31/2026
-
SeekingAlpha
8/31/2026
-
The Cerbat Gem
8/31/2026
-
TipRanks
8/31/2026
-
TipRanks
8/31/2026
-
The Cerbat Gem
8/31/2026
-
TipRanks: TheFly
8/31/2026
-
SeekingAlpha.com: All News
8/31/2026
-
PR Newswire
8/28/2026
-
SeekingAlpha.com: All News
8/28/2026
-
Seeking Alpha - Healthcare
8/28/2026
-
Seeking Alpha - Israel Stocks
8/28/2026
-
TipRanks: TheFly
8/28/2026
-
PR Newswire
8/25/2026
-
PR Newswire
8/18/2026
-
TipRanks
7/20/2026
-
PR Newswire
7/8/2026
-
TipRanks
7/8/2026
-
TipRanks: TheFly
7/8/2026
-
PR Newswire
6/28/2026
-
The Cerbat Gem
5/29/2026
-
Nasdaq News: Markets
5/29/2026
-
Fool.com Headlines
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 31, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 8 642 9100
Address
Modi’in Technology Park
2 HaMa’ayan Street
Hevel Modi'in, 7177871
2 HaMa’ayan Street
Hevel Modi'in, 7177871
Country
Year Founded
Business Description
Sector
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company’s pipeline includes GLIX1, an oral, small molecule targeting DNA...
more